🏛️ Verified NIH Record • Updated 2025-10-02
Kaneka Endovascular Embolization and Protection (NCT05563051)
🔵 Active, Not Recruiting Observational / Diagnostic ⚙️ Medical Device Protocol Sponsor: Kaneka Medical America LLC
🩺 Plain-English Summary (8th-Grade Level)
Prospective, multi-center, non-randomized registry / study, up to 164 patients enrolled and followed at 180 days +/- 45 days and again at 365 days +/- 90 days post procedure
Who can join: Review the eligibility criteria below.
Location: McLaren Health Care — Grand Blanc, Michigan
Age range: 18 Years to 80 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (4 Sites)
- McLaren Health Care — Grand Blanc, Michigan
- Northwell Health Lenox Hill Hospital — New York, New York
- Cleveland Clinic — Cleveland, Ohio
- SSM Health St. Anthony's Hospital — Oklahoma City, Oklahoma
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Aneurysm Cerebral
- Perioperative Risk in Patients on Chronic Aspirin Undergoing Craniotomy — Jacksonville, Florida
- LUMENS-1 Canada Early Feasibility Study Clinical Investigation Plan — Toronto, Ontario
- The TERUMO FRED X EARLY FEASIBILITY STUDY (FAST) STUDY. — Buffalo, New York
Explore by condition: All Aneurysm Cerebral clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.